These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21161615)

  • 21. Deleterious effect of HIV-1 plasma viremia on B cell costimulatory function.
    Malaspina A; Moir S; Kottilil S; Hallahan CW; Ehler LA; Liu S; Planta MA; Chun TW; Fauci AS
    J Immunol; 2003 Jun; 170(12):5965-72. PubMed ID: 12794123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B lymphocyte dysfunctions in HIV infection.
    De Milito A
    Curr HIV Res; 2004 Jan; 2(1):11-21. PubMed ID: 15053337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting human langerin promotes HIV-1 specific humoral immune responses.
    Kervevan J; Bouteau A; Lanza JS; Hammoudi A; Zurawski S; Surenaud M; Dieudonné L; Bonnet M; Lefebvre C; Hocini H; Marlin R; Guguin A; Hersant B; Hermeziu O; Menu E; Lacabaratz C; Lelièvre JD; Zurawski G; Godot V; Henri S; Igyártó BZ; Levy Y; Cardinaud S
    PLoS Pathog; 2021 Jul; 17(7):e1009749. PubMed ID: 34324611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assays.
    Kutscher S; Allgayer S; Dembek CJ; Bogner JR; Protzer U; Goebel FD; Erfle V; Cosma A
    Gene Ther; 2010 Nov; 17(11):1372-83. PubMed ID: 20535218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies from Rabbits Immunized with HIV-1 Clade B SOSIP Trimers Can Neutralize Multiple Clade B Viruses by Destabilizing the Envelope Glycoprotein.
    van Haaren MM; McCoy LE; Torres JL; Lee W; Cottrell CA; Copps JL; van der Woude P; Yasmeen A; de Taeye SW; Torrents de la Peña A; Moore JP; Burton DR; Klasse PJ; Ward AB; Sanders RW; van Gils MJ
    J Virol; 2021 Aug; 95(17):e0009421. PubMed ID: 34076487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4+ T-cell help enhances NK cell function following therapeutic HIV-1 vaccination.
    Jost S; Tomezsko PJ; Rands K; Toth I; Lichterfeld M; Gandhi RT; Altfeld M
    J Virol; 2014 Aug; 88(15):8349-54. PubMed ID: 24829350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene combination raises broad human immunodeficiency virus-specific cytotoxicity.
    Calarota SA; Kjerrström A; Islam KB; Wahren B
    Hum Gene Ther; 2001 Sep; 12(13):1623-37. PubMed ID: 11535166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.
    Letvin NL; Huang Y; Chakrabarti BK; Xu L; Seaman MS; Beaudry K; Korioth-Schmitz B; Yu F; Rohne D; Martin KL; Miura A; Kong WP; Yang ZY; Gelman RS; Golubeva OG; Montefiori DC; Mascola JR; Nabel GJ
    J Virol; 2004 Jul; 78(14):7490-7. PubMed ID: 15220422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo analysis of Nef's role in HIV-1 replication, systemic T cell activation and CD4(+) T cell loss.
    Watkins RL; Foster JL; Garcia JV
    Retrovirology; 2015 Jul; 12():61. PubMed ID: 26169178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH.
    Malm M; Rollman E; Ustav M; Hinkula J; Krohn K; Wahren B; Blazevic V
    Viral Immunol; 2005; 18(4):678-88. PubMed ID: 16359234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viral and host factors in the pathogenesis of HIV infection.
    Derdeyn CA; Silvestri G
    Curr Opin Immunol; 2005 Aug; 17(4):366-73. PubMed ID: 15955686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incomplete Downregulation of CD4 Expression Affects HIV-1 Env Conformation and Antibody-Dependent Cellular Cytotoxicity Responses.
    Prévost J; Richard J; Medjahed H; Alexander A; Jones J; Kappes JC; Ochsenbauer C; Finzi A
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Robust antigen-specific humoral immune responses to sublingually delivered adenoviral vectors encoding HIV-1 Env: association with mucoadhesion and efficient penetration of the sublingual barrier.
    Domm W; Brooks L; Chung HL; Feng C; Bowers WJ; Watson G; McGrath JL; Dewhurst S
    Vaccine; 2011 Sep; 29(40):7080-9. PubMed ID: 21801777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nef-mediated enhancement of cellular activation and human immunodeficiency virus type 1 replication in primary T cells is dependent on association with p21-activated kinase 2.
    Olivieri KC; Mukerji J; Gabuzda D
    Retrovirology; 2011 Aug; 8():64. PubMed ID: 21819585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.
    Bogers WMJM; Barnett SW; Oostermeijer H; Nieuwenhuis IG; Beenhakker N; Mortier D; Mooij P; Koopman G; Remarque E; Martin G; Lai RP; Dey AK; Sun Y; Burke B; Ferrari G; Montefiori D; Martin L; Davis D; Srivastava I; Heeney JL
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adaptation of an R5 Simian-Human Immunodeficiency Virus Encoding an HIV Clade A Envelope with or without Ablation of Adaptive Host Immunity: Differential Selection of Viral Mutants.
    Zhou M; Humbert M; Mukhtar MM; Scinto HB; Vyas HK; Lakhashe SK; Byrareddy SN; Maurer G; Thorat S; Owuor J; Lai Z; Chen Y; Griffiths A; Chenine AL; Gumber S; Villinger F; Montefiori D; Ruprecht RM
    J Virol; 2019 May; 93(9):. PubMed ID: 30760566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational design of vaccines to elicit broadly neutralizing antibodies to HIV-1.
    Kwong PD; Mascola JR; Nabel GJ
    Cold Spring Harb Perspect Med; 2011 Sep; 1(1):a007278. PubMed ID: 22229123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulatory T cell abundance and activation status before and after priming with HIVIS-DNA and boosting with MVA-HIV/rgp140/GLA-AF may impact the magnitude of the vaccine-induced immune responses.
    Chissumba RM; Luciano A; Namalango E; Bauer A; Bhatt N; Wahren B; Nilsson C; Geldmacher C; Scarlatti G; Jani I; Kestens L;
    Immunobiology; 2018 Dec; 223(12):792-801. PubMed ID: 30121146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoire.
    Casazza JP; Bowman KA; Adzaku S; Smith EC; Enama ME; Bailer RT; Price DA; Gostick E; Gordon IJ; Ambrozak DR; Nason MC; Roederer M; Andrews CA; Maldarelli FM; Wiegand A; Kearney MF; Persaud D; Ziemniak C; Gottardo R; Ledgerwood JE; Graham BS; Koup RA;
    J Infect Dis; 2013 Jun; 207(12):1829-40. PubMed ID: 23482645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART.
    Ensoli B; Bellino S; Tripiciano A; Longo O; Francavilla V; Marcotullio S; Cafaro A; Picconi O; Paniccia G; Scoglio A; Arancio A; Ariola C; Ruiz Alvarez MJ; Campagna M; Scaramuzzi D; Iori C; Esposito R; Mussini C; Ghinelli F; Sighinolfi L; Palamara G; Latini A; Angarano G; Ladisa N; Soscia F; Mercurio VS; Lazzarin A; Tambussi G; Visintini R; Mazzotta F; Di Pietro M; Galli M; Rusconi S; Carosi G; Torti C; Di Perri G; Bonora S; Ensoli F; Garaci E
    PLoS One; 2010 Nov; 5(11):e13540. PubMed ID: 21085635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.